Evidence map›Paper›PMID 34992676›Full record

ArticleComputational and mathematical methods in medicine2021

Alzheimer's Disease Classification Based on Image Transformation and Features Fusion.

Hongfei Jia, Yu Wang, Yifan Duan, Hongbing Xiao

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Focal-DenseNet: A Risk Assessment Framework for Alzheimer's Disease in Heterogeneous MRI Data.Interdisciplinary sciences, computational life sciences · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hongfei JiaBeijing Key Laboratory of Big Data Technology for Food Safety, School of Artificial Intelligence, Beijing Technology and Business University, Beijing 100048, China.ORCID https://orcid.org/0000-0002-5732-2487
Yu WangBeijing Key Laboratory of Big Data Technology for Food Safety, School of Artificial Intelligence, Beijing Technology and Business University, Beijing 100048, China.ORCID https://orcid.org/0000-0002-2210-7461
Yifan DuanBeijing Key Laboratory of Big Data Technology for Food Safety, School of Artificial Intelligence, Beijing Technology and Business University, Beijing 100048, China.ORCID https://orcid.org/0000-0003-2323-8460
Hongbing XiaoBeijing Key Laboratory of Big Data Technology for Food Safety, School of Artificial Intelligence, Beijing Technology and Business University, Beijing 100048, China.ORCID https://orcid.org/0000-0003-3432-1200
Beijing Technology and Business University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has become an inevitable trend for medical personnel to analyze and diagnose Alzheimer's disease (AD) in different stages by combining functional magnetic resonance imaging (fMRI) and artificial intelligence technologies such as deep learning in the future. In this paper, a classification method was proposed for AD based on two different transformation images of fMRI and improved the 3DPCANet model and canonical correlation analysis (CCA). The main ideas include that, firstly, fMRI images were preprocessed, and subsequently, mean regional homogeneity (mReHo) and mean amplitude of low-frequency amplitude (mALFF) transformation were performed for the preprocessed images. Then, mReHo and mALFF images were extracted features using the improved 3DPCANet, and these two kinds of the extracted features were fused by CCA. Finally, the support vector machine (SVM) was used to classify AD patients with different stages. Experimental results showed that the proposed approach was robust and effective. Classification accuracy for significant memory concern (SMC) vs. mild cognitive impairment (MCI), normal control (NC) vs. AD, and NC vs. SMC, respectively, reached 95.00%, 92.00%, and 91.30%, which adequately proved the feasibility and effectiveness of the proposed method.

Indexed as

AlgorithmsAlzheimer DiseaseArtificial IntelligenceBrainCanonical Correlation AnalysisCognitive DysfunctionComputational BiologyFunctional NeuroimagingHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingSupport Vector Machine

Identifiers

PMID34992676
PMCPMC8727120
OpenAlexW4200227607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.